Reuters logo
BRIEF-Moleculin's WP1066 Drug Gets FDA Brain Tumor IND Clearance
December 5, 2017 / 12:11 PM / 10 days ago

BRIEF-Moleculin's WP1066 Drug Gets FDA Brain Tumor IND Clearance

Dec 5 (Reuters) - Moleculin Biotech Inc:

* MOLECULIN‘S WP1066 DRUG GETS FDA BRAIN TUMOR IND CLEARANCE

* MOLECULIN BIOTECH-IND APPLICATION FOR PHASE I TRIAL OF WP1066 IN PATIENTS WITH RECURRENT MALIGNANT GLIOMA, BRAIN METASTASIS FROM MELANOMA, ALLOWED BY FDA Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below